Clinical trial
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
NCT05210504 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 9, 2022
- Completion date
- January 27, 2023
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.